Director Sells 33,000 Impinj: Insider Move to Watch
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
Zero Based Budgeting Basics
Dive into the basics of zero based budgeting and learn to allocate every dollar effectively. Start budgeting smarter today!
15,768 articles
Nebius Group Just Became a Major AI Infrastructure Player
Nebius Group wins approval to build a 1.2 GW AI factory in Independence, Missouri, signaling a major shift in U.S. AI...
Transcript: Carl Richards Sketching Wealth Strategy
A practical guide to using sketches to plan and manage wealth. Learn how Carl Richards' visual approach helps you tra...
Live: Will Veeva Systems Rally After Q4 Earnings Tonight?
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
Figure Says $300m Prefunded Securitization Gains Certainty
Figure has closed a $300 million fully prefunded securitization for loans to be traded on its Figure Connect marketpl...
Top Stocks Double Right Now: Smart Picks for 2026 Investing
Bold claims about doubling your money tempt investors. This guide explains realistic paths to potential outsized gain...
A.I. Tackling Risk “Digital” in Personal Finance Today
A Dutch court halted a welfare-detection AI system over privacy and bias concerns, prompting watchdogs to weigh tight...
1,012% Year Return Could Not Shield KORU From Its Structure
KORU, the 3X South Korea ETF, tumbles about 28% in a single week even as it posted massive prior gains. The selloff u...
CoreWeave, Nebius Shares Tumble as Meta Threat Grows
Meta's plan to monetize AI infrastructure roils cloud peers, sending private-market signals lower for CoreWeave and N...
Amprius (AMPX) 2025 Earnings: Investor Outlook and Trends
Amprius (AMPX) 2025 earnings offer insight into a niche but promising battery player. This article breaks down what t...
Masterclass Pricing Power Makes Altria a Retirement Fortress
Altria's pricing power has shifted the stock into a retirement fortress, delivering durable cash flow and a high-yiel...
Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status